Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Sæbø, Mona ^a   Skjelbred, Camilla Furu ^a,b   Nexø, Bjørn Andersen ^c   Wallin, Håkan ^d   Hansteen, Inger Lise ^b   Vogel, Ulla ^d   Kure, Elin H ^a,e  

^a UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^b TELEMARK HOSPITAL   (Norway)

^c AARHUS UNIVERSITY   (Denmark)

^d NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

8 OXOGUANINE GLYCOSYLASE 1; DNA GLYCOSYLTRANSFERASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MESSENGER RNA; RAL PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; DNA REPAIR; EARLY CANCER; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADENOMA; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA GLYCOSYLASES; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; REPRESSOR PROTEINS; RNA, MESSENGER;

EID: 33748660078     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-208     Document Type: Article

References (40)

1. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87(2):159-170.
2. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61(5):759-767.
3. Dybdahl M, Frentz G, Vogel U, Wallin H, Nexo BA: Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. Mutat Res 1999, 433(1):15-22.
4. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L: DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J Invest Dermatol 1995, 104(6):933-936.
5. Wei Q, Cheng L, Hong WK, Spitz MR: Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996, 56(18):4103-4107.
6. Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q: Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1998, 7(6):465-468.
7. Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q: Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 2004, 25(9):1695-1700.
8. Benhamou S, Sarasin A: Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 2000, 462(2-3):149-158.
9. Wilson DM 3rd, Thompson LH: Life without DNA repair. Proc Natl Acad Sci USA 1997, 94(24):12754-12757.
10. Tsurudome Y, Hirano T, Yamato H, Tanaka I, Sagai M, Hirano H, Nagata N, Itoh H, Kasai H: Changes in levels of 8-hydroxyguanine in DNA, its repair and OGGI mRNA in rat lungs after intratracheal administration of diesel exhaust particles. Carcinogenesis 1999, 20(8):1573-1576.
11. Cheng L, Guan Y, Li L, Legerski RJ, Einspahr J, Bangert J, Alberts DS, Wei Q: Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 1999, 8(9):801-807.
12. Dabholkar M, Bostick-Bruton F, Weber C, Egwuagu C, Bohr VA, Reed E: Expression of excision repair genes in non-malignant bone marrow from cancer patients. Mutat Res 1993, 293(2):151-160.
13. Vogel U, Dybdahl M, Frentz G, Nexo BA: DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat Res 2000, 461(3):197-210.
14. Kondo S, Toyokuni S, Tanaka T, Hiai H, Onodera H, Kasai H, Imamura M: Overexpression of the hOGGI gene and high 8-hydroxy-2′-deoxyguanosine (B-OHdG) lyase activity in human colorectal carcinoma: regulation mechanism of the 8-OHdG level in DNA. Clin Cancer Res 2000, 6(4):1394-1400.
15. Li Q, Yu JJ, Mu C, Yunmbam MK, Slavsky D, Cross CL, Bostick-Bruton F, Reed E: Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells. Anticancer Res 2000, 20(2A):645-652.
16. van Duin M, de Wit J, Odijk H, Westerveld A, Yasui A, Koken HM, Hoeijmakers JH, Bootsma D: Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell 1986, 44(6):913-923.
17. Wood RD: Nucleotide excision repair in mammalian cells. J Biol Chem 1997, 272(38):23465-23468.
18. Metzger R, Leichman CG, Danenberg KD, Danenberg PV, Lenz HJ, Hayashi K, Groshen S, Salonga D, Cohen H, Laine L, et al.: ERCCI mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol 1998, 16(1):309-316.
19. Lord RV, Brabender J, Gandara D, Alberola V, Camps C, Domine M, Cardenal F, Sanchez JM, Gumerlock PH, Taron M, et al.: Low ERCCI expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin Cancer Res 2002, 8(7):2286-2291.
20. Rosell R, Taron M, Ariza A, Barnadas A, Mate JL, Reguart N, Margel M, Felip E, Mendez P, Garcia-Campelo R: Molecular predictors of response to chemotherapy in lung cancer. Semin Oncol 2004, 31 (1 Suppl 1):20-27.
21. Shirota Y, Stoehlmacher J, Brabender J, Xiong YP, Uetake H, Danenberg KD, Groshen S, Tsao-Wei DD, Danenberg PV, Lenz HJ: ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol 2001, 19(23):4298-4304.
22. Vogel U, Moller P, Dragsted L, Loft S, Pedersen A, Sandstrom B: Inter-individual variation, seasonal variation and close correlation of OGG1 and ERCC1 mRNA levels in full blood from healthy volunteers. Carcinogenesis 2002, 23(9):1505-1509.
23. Radicella JP, Dherin C, Desmaze C, Fox MS, Boiteux S: Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1997, 94(15):8010-8015.
24. Aburatani H, Hippo Y, Ishida T, Takashima R, Matsuba C, Kodama T, Takao M, Yasui A, Yamamoto K, Asano M: Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res 1997, 57(11):2151-2156.
25. Kondo S, Toyokuni S, Iwasa Y, Tanaka T, Onodera H, Hiai H, Imamura M: Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic Biol Med 1999, 27(3-4):401-410.
26. Bancroft LK, Lupton JR, Davidson LA, Taddeo SS, Murphy ME, Carroll RJ, Chapkin RS: Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic Biol Med 2003, 35(2):149-159.
27. Kim HN, Morimoto Y, Tsuda T, Ootsuyama Y, Hirohashi M, Hirano T, Tanaka I, Lim Y, Yun IG, Kasai H: Changes in DNA 8-hydroxyguanine levels, 8-hydroxyguanine repair activity, and hOGG1 and hMTH1 mRNA expression in human lung alveolar epithelial cells induced by crocidolite asbestos. Carcinogenesis 2001, 22(2):265-269.
28. Yang JP, Hori M, Sanda T, Okamoto T: Identification of a novel inhibitor of nuclear factor-kappaB, ReIA-associated inhibitor. J Biol Chem 1999, 274(22):15662-15670.
29. Yin J, Rockenbauer E, Hedayati M, Jacobsen NR, Vogel U, Grossman L, Bolund L, Nexo BA: Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of Basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2002, 11(11):1449-1453.
30. Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh JK, O'Connor DJ, Zhong S, Campargue I, Tomlinson ML, et al.: IASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 2003, 33(2):162-167.
31. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G: The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003, 38(6):635-642.
32. [http://www.clinicaltrials.gov].
33. Hansen R, Saebo M, Skjelbred CF, Nexo BA, Hagen PC, Bock G, Bowitz Lothe IM, Johnson E, Aase S, Hansteen IL, et al.: GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett 2005, 229(1):85-91.
34. Vogel U, Nexo BA, Tjonneland A, Wallin H, Hertel O, Raaschou-Nielsen O: ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes. Mutat Res 2006, 593(1-2):88-96.
35. Wei Q, Xu X, Cheng L, Legerski RJ, Ali-Osman F: Simultaneous amplification of four DNA repair genes and beta-actin in human lymphocytes by multiplex reverse transcriptase-PCR. Cancer Res 1995, 55(21):5025-5029.
36. Zhang X, Wang M, Zhou C, Chen S, Wang J: The expression of iASPP in acute leukemias. Leuk Res 2005, 29(2):179-183.
37. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, Livneh Z: DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 2003, 95(17):1312-1319.
38. Vogel U, Nexo BA, Tjonneland A, Wallin H, Hertel O, Raaschou-Nielsen O: ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes. Mutat Res 2005.
39. Hansen R, Saebo M, Skjelbred CF, Nexo BA, Hagen PC, Bock G, Bowitz Lothe IM, Johnson E, Aase S, Hansteen IL, et al.: GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectall cancer. Cancer Lett 2005.
40. Yamane A, Kohno T, Ito K, Sunaga N, Aoki K, Yoshimura K, Murakami H, Nojima Y, Yokota J: Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 2004, 25(9):1689-1694.